Last reviewed · How we verify
NCT03256006: TRAIL PHYSIO
Study Inflammation During a 100 Miles
trial testing Blood sample in Inflammatory Response in 20 participants. Status unknown.
18 October 2018
Quick facts
| Lead sponsor | Hôpital Necker-Enfants Malades |
|---|---|
| Status | Status unknown |
| Study type | OBSERVATIONAL |
| Enrollment | 20 |
| Start date | 18 October 2018 |
| Primary completion | 18 October 2018 |
| Estimated completion | 29 October 2018 |
Drugs / interventions tested
- Blood sample — full drug profile →
Conditions studied
- Inflammatory Response — all drugs for Inflammatory Response →
Sponsor
Hôpital Necker-Enfants Malades — full company profile →
Who can join
Adults 18 to 75, male only, with Inflammatory Response. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
To study per and post effort variations of inflammatory biological markers during a 100 miles
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT03256006
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Blood sample
Trials testing the same drug.
- NCT07226466 — Evaluating Biomarkers of Cognitive Dysfunction in Patients With Cancer · not yet recruiting
- NCT07313878 — Evaluation of Acute and Chronic Nephrotoxicity in Acute Lymphatic Leukemia Patients Using Ultrasound Localization Micros · NA · recruiting
- NCT06273800 — Chemosensitivity During Phases of the Menstrual Cycle in Breast Cancer Patients · NA · recruiting
- NCT07030205 — Resting-state Imaging and OSteoporosiS · NA · recruiting
- NCT07295808 — Identification and Characterisation of IgA With Nephritogenic Potential in IgA Deposition Nephropathies (Rep-IgAN) · NA · recruiting
Other recruiting trials for Inflammatory Response
Currently open trials in the same condition.
- NCT06450704 — Cerebral and Anti-inflammatory Response Through Exercise - Mechanisms In Depressive Disorders · NA · recruiting
- NCT06519487 — Social Experiences and Demographic Factors in the Regulation of Immune Cells · NA · recruiting
- NCT06434701 — Severe COVID-19 Infection in Children Presenting to EDs in Israel and England · NA · recruiting
- NCT06491966 — Clinical Outcomes and Inflammatory Responses in Viral vs. Bacterial Sepsis · recruiting
- NCT06342024 — Pistachio Consumption on Inflammatory Markers and Lean Body Mass · NA · active not recruiting
Other Hôpital Necker-Enfants Malades trials
Trials by the same sponsor.
- NCT06300567 — Assessment of Patients Not Concluded After Neonatal Screening of Cystic Fibrosis. · not yet recruiting
- NCT04490811 — Seroprevalence and Immunoprotection Against COVID-19 in Parisian Children · unknown
- NCT04561466 — Trial of Befizal® 200 mg for the Treatment of Leber Hereditary Optic Neuropathy · Phase 2, PHASE3 · completed
- NCT03831022 — Usefulness of Capillary Refill Time and Skin Mottling Score to Predict Intensive Care Unit Admission · unknown
- NCT03194035 — Inflammation in an Ultra Endurance Race · unknown
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03256006 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Hôpital Necker-Enfants Malades
- Last refreshed: 3 August 2018
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03256006.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing